The impact of mgrA on progression of Staphylococcus aureus sepsis

Cai-lin Liu1, Zhong-ju Chen1, Feng Wang1

  • 1Department of Laboratory Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.

Microbial Pathogenesis
|April 22, 2014
PubMed

Insights

The global regulator MgrA in Staphylococcus aureus significantly increases sepsis mortality and severity. Deleting mgrA in mice reduced mortality, bacterial load, and inflammation, indicating its crucial role in sepsis progression.

Area of Science:

  • Microbiology
  • Immunology
  • Pathogenesis

Background:

  • Staphylococcus aureus infections, particularly methicillin-resistant strains (MRSA), lead to severe sepsis with high mortality.
  • Virulence factors are key in S. aureus pathogenesis.
  • MgrA is a global regulator controlling virulence factor expression in S. aureus.

Purpose of the Study:

  • To investigate the role of the global regulator MgrA in the onset and progression of Staphylococcus aureus-induced sepsis using a murine model.

Main Methods:

  • A murine model of sepsis was utilized.
  • Comparison between wild-type Newman strain and mgrA knockout strain of S. aureus.

Main Results:

  • Mice infected with wild-type S. aureus exhibited significantly higher mortality (p=0.029) compared to the mgrA knockout strain.
  • Wild-type infections led to greater weight loss, increased bacterial load in blood, spleen, and kidneys, heightened inflammation, and worse histopathology.
  • MgrA plays a critical role in S. aureus sepsis, increasing mortality and accelerating disease development.

Conclusions:

  • MgrA is a crucial global regulator in Staphylococcus aureus.
  • MgrA significantly contributes to the severity and mortality of S. aureus-induced sepsis.
  • Targeting MgrA could be a potential therapeutic strategy for S. aureus sepsis.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
143
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
219